UCL Medical School Royal Free CampusLondon, United Kingdom
Rheumatologist
1589: Nintedanib in Systemic Sclerosis-Associated Interstitial Lung disease: Real-World Cohort Study on Tolerability and Discontinuation
Monday, October 27, 202510:30 AM - 12:30 PM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose